Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect

Purpose: To determine if pulsed-high intensity focused ultrasound (HIFU) could effectively serve as a source of hyperthermia with thermosensitive liposomes to enhance delivery and efficacy of doxorubicin in tumors. Experimental Design: Comparisons in vitro and in vivo were carried out between non–thermosensitive liposomes (NTSL) and low temperature–sensitive liposomes (LTSL). Liposomes were incubated in vitro over a range of temperatures and durations, and the amount of doxorubicin released was measured. For in vivo experiments, liposomes and free doxorubicin were injected i.v. in mice followed by pulsed-HIFU exposures in s.c. murine adenocarcinoma tumors at 0 and 24 h after administration. Combinations of the exposures and drug formulations were evaluated for doxorubicin concentration and growth inhibition in the tumors. Results:In vitro incubations simulating the pulsed-HIFU thermal dose (42°C for 2 min) triggered release of 50% of doxorubicin from the LTSLs; however, no detectable release from the NTSLs was observed. Similarly, in vivo experiments showed that pulsed-HIFU exposures combined with the LTSLs resulted in more rapid delivery of doxorubicin as well as significantly higher i.t. concentration when compared with LTSLs alone or NTSLs, with or without exposures. Combining the exposures with the LTSLs also significantly reduced tumor growth compared with all other groups. Conclusions: Combining low-temperature heat-sensitive liposomes with noninvasive and nondestructive pulsed-HIFU exposures enhanced the delivery of doxorubicin and, consequently, its antitumor effects. This combination therapy could potentially produce viable clinical strategies for improved targeting and delivery of drugs for treatment of cancer and other diseases.

[1]  Ivan Spasojevic,et al.  Phase I Trial of Doxorubicin-Containing Low Temperature Sensitive Liposomes in Spontaneous Canine Tumors , 2006, Clinical Cancer Research.

[2]  Hans Stødkilde-Jørgensen,et al.  MRI-guided focused ultrasound: methodology and applications , 2006, IEEE Transactions on Medical Imaging.

[3]  V. Frenkel,et al.  Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. , 2006, Academic radiology.

[4]  Victor Frenkel,et al.  Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. , 2006, Radiology.

[5]  Wilson Mok,et al.  Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. , 2006, Cancer research.

[6]  Victor Frenkel,et al.  Potential role of pulsed-high intensity focused ultrasound in gene therapy. , 2006, Future oncology.

[7]  Q. Bashir,et al.  Cardiotoxicity of cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. Moonen,et al.  Local delivery of magnetic resonance (MR) contrast agent in kidney using thermosensitive liposomes and MR imaging‐guided local hyperthermia: A feasibility study in vivo , 2005, Journal of magnetic resonance imaging : JMRI.

[9]  J. Kennedy High-intensity focused ultrasound in the treatment of solid tumours , 2005, Nature Reviews Cancer.

[10]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[11]  K. Hynynen,et al.  MRI guided and monitored focused ultrasound thermal ablation methods: a review of progress , 2004, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  M. Dewhirst,et al.  In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.

[13]  Natalia Vykhodtseva,et al.  Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney. , 2004, Radiology.

[14]  Douglas L. Miller,et al.  Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. , 2003, Ultrasound in medicine & biology.

[15]  Takashi Azuma,et al.  Effect of split-focus approach on producing larger coagulation in swine liver. , 2003, Ultrasound in medicine & biology.

[16]  D. Tzemach,et al.  Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models , 2002, Journal of drug targeting.

[17]  A. Gabizon Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy , 2001, Cancer investigation.

[18]  M. Dewhirst,et al.  Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. , 2000, Cancer research.

[19]  Mark W. Dewhirst,et al.  Review Hyperthermia and liposomes , 1999 .

[20]  M. Dewhirst,et al.  Hyperthermia and liposomes. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  K. Tolba,et al.  Cardiotoxicity of cancer therapy. , 1999, Cancer investigation.

[22]  T. Nishita Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor. , 1998, Osaka city medical journal.

[23]  M. Burton,et al.  Enhanced Anticancer Therapy Mediated by Specialized Liposomes , 1997, The Journal of pharmacy and pharmacology.

[24]  A. Howell,et al.  Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  D. Tzemach,et al.  Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals , 1997 .

[26]  T. Allen,et al.  Liposomes , 2012, Drugs.

[27]  M. Dewhirst,et al.  Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. , 1996, International journal of radiation oncology, biology, physics.

[28]  K Hynynen,et al.  Noninvasive arterial occlusion using MRI-guided focused ultrasound. , 1996, Ultrasound in medicine & biology.

[29]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[30]  R K Jain,et al.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. , 1990, Cancer research.

[31]  B. Khoobehi,et al.  Hyperthermia and temperature-sensitive liposomes: selective delivery of drugs into the eye. , 1989, Japanese journal of ophthalmology.

[32]  J. Weinstein,et al.  Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate. , 1980, Cancer research.